Best Split Virion, Inactivate Service & Product

Advanced Viral Inactivation Solutions & High-Purity Pharmaceutical Ingredients for Global Biosecurity and Health Stability.

Global Industrial Status: The Evolution of Split Virion Technology

The global biopharmaceutical industry is witnessing a paradigm shift toward Split Virion and Inactivation technologies. Unlike traditional whole-virus vaccines, split virion technology involves the use of detergents (such as Triton X-100) or solvents to disrupt the viral envelope. This process effectively "splits" the virus into its constituent proteins, specifically targeting hemagglutinin (HA) and neuraminidase (NA) for influenza vaccines, which results in a product with significantly lower reactogenicity while maintaining high immunogenicity.
⚙️

Precision Inactivation

Utilizing Formaldehyde or Beta-propiolactone (BPL) to ensure complete viral neutralization without compromising structural integrity of antigens.

🛡️

Enhanced Safety

The "Split" process removes much of the viral internal components that cause high fever and local reactions in pediatric and geriatric populations.

🌐

Global Regulatory Compliance

Meeting rigorous WHO, FDA, and EMA standards for viral clearance and residual detergent monitoring.

China’s Manufacturing Edge: Efficiency, Scale, and Quality

China has emerged as a global hub for pharmaceutical manufacturing, specifically within the Jiangxi Serum Pharma ecosystem. The efficiency of Chinese factories is not merely a result of labor scale but stems from Vertical Integration and Smart Automation.
1
Rapid Prototyping: The ability to move from viral seed to pilot-scale split virion production in 30% less time than Western counterparts.
2
Cost Optimization: Leveraging localized supply chains for raw materials, intermediates, and consumables, reducing the final price for global NGOs and healthcare providers.
3
GMP Rigor: Chinese facilities now boast world-class GMP certifications, ensuring that "Made in China" is synonymous with high purity and global safety standards.
4
Infrastructure: Advanced cold-chain logistics integrated directly into factory hubs, ensuring zero-loss transport for sensitive biologicals.

Pharmaceutical & Nutritional Products Specialist

Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts.
2017Established Year
500+Long-term Clients
200+Key Suppliers
$10M+Annual Sales (USD)

Localized Application Scenarios: From Clinics to Large-scale Industry

The application of Split Virion Inactivation services transcends human vaccines. Our solutions are tailored for diverse high-impact scenarios:

Seasonal Immunization

Providing the high-purity HA/NA antigens required for annual trivalent and quadrivalent influenza vaccines used in public health programs.

Veterinary Biologics

Protecting livestock and poultry through inactivated viral solutions, ensuring food security in the agricultural sector.

Emergency Response

Rapid scale-up of inactivated viral components for pandemic preparedness and "Disease X" mitigation strategies.

Bioreactor Optimization

Our services include the customization of Bio-Fermentation and Pre-Mix solutions, enabling local manufacturers to bypass the complex initial stages of virion splitting.

Industry Trends & Procurement Strategy

As we look toward 2030, the demand for "Clean-Label" Biologics—those with minimal residuals and no thimerosal—is surging. Global procurement teams are shifting focus from "lowest cost" to "Total Supply Chain Resilience."
📈
Market Growth: The inactivated vaccine segment is expected to grow at a CAGR of 7.4%, driven by the accessibility of these products in developing nations where ultra-cold chain infrastructure is limited.
🏢
Procurement Insight: Large-scale buyers now require "Information Gain"—they need data-driven assurance of viral clearance ratios and purity levels above 99.5% for API and split virion intermediates.

Frequently Asked Questions (FAQ)

What is the difference between Whole Virion and Split Virion vaccines?
Whole virion vaccines contain the entire inactivated virus. Split virion vaccines go a step further by using detergents to disrupt the virus, leaving only the essential antigenic parts. This significantly reduces side effects like fever.
How does Jiangxi Serum Pharma ensure the quality of its Inactivation Service?
We adhere to international GMP standards, utilizing validated inactivation kinetics studies to ensure a 100% kill rate while preserving the delicate protein structures needed for an immune response.
Can you provide customized Pre-Mix or Co-Crystallization products?
Yes, we have collaborated with partners to offer specialized customization for Pre-Mix, Co-Crystallization, and Bio-Fermentation services to meet specific industrial requirements.
What are the main export markets for your pharmaceutical products?
With over 500 long-term clients, we export globally, focusing on markets that require high-quality GMP/BP/USP compliant medicines and biologicals.